 Todd Wine
Concepts (215)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Otitis Media | 9 | 2024 | 180 | 1.470 |
Why?
| | Nasal Obstruction | 2 | 2021 | 26 | 1.060 |
Why?
| | Tracheal Diseases | 3 | 2019 | 15 | 0.950 |
Why?
| | Myringoplasty | 1 | 2020 | 2 | 0.640 |
Why?
| | Direct Service Costs | 1 | 2020 | 8 | 0.640 |
Why?
| | Tracheomalacia | 4 | 2022 | 17 | 0.640 |
Why?
| | Tympanic Membrane | 1 | 2020 | 21 | 0.630 |
Why?
| | Nasal Cavity | 3 | 2025 | 62 | 0.620 |
Why?
| | Cutaneous Fistula | 2 | 2019 | 14 | 0.560 |
Why?
| | Hyaluronic Acid | 1 | 2020 | 223 | 0.540 |
Why?
| | Bronchoscopy | 8 | 2021 | 227 | 0.530 |
Why?
| | Airway Obstruction | 3 | 2021 | 153 | 0.510 |
Why?
| | Adipose Tissue | 1 | 2020 | 643 | 0.460 |
Why?
| | Trachea | 6 | 2021 | 258 | 0.450 |
Why?
| | Otorhinolaryngologic Surgical Procedures | 2 | 2014 | 38 | 0.420 |
Why?
| | Palatal Neoplasms | 1 | 2013 | 6 | 0.390 |
Why?
| | Palate, Soft | 1 | 2013 | 11 | 0.390 |
Why?
| | Brachiocephalic Trunk | 1 | 2013 | 11 | 0.390 |
Why?
| | Leiomyoma | 1 | 2013 | 59 | 0.380 |
Why?
| | Common Cold | 1 | 2012 | 16 | 0.380 |
Why?
| | Head and Neck Neoplasms | 3 | 2013 | 562 | 0.370 |
Why?
| | Tracheostomy | 3 | 2020 | 142 | 0.360 |
Why?
| | Robotics | 1 | 2013 | 89 | 0.350 |
Why?
| | Calcinosis | 1 | 2013 | 234 | 0.340 |
Why?
| | Child, Preschool | 19 | 2026 | 11790 | 0.340 |
Why?
| | Tracheoesophageal Fistula | 2 | 2022 | 40 | 0.330 |
Why?
| | Adenoidectomy | 2 | 2024 | 81 | 0.330 |
Why?
| | Retrospective Studies | 18 | 2026 | 17149 | 0.320 |
Why?
| | Sarcoma | 1 | 2013 | 203 | 0.320 |
Why?
| | Aorta, Thoracic | 1 | 2013 | 285 | 0.320 |
Why?
| | Fucosyltransferases | 2 | 2022 | 33 | 0.310 |
Why?
| | Infant | 14 | 2026 | 10023 | 0.300 |
Why?
| | Tracheal Stenosis | 2 | 2023 | 39 | 0.300 |
Why?
| | Child | 22 | 2026 | 22600 | 0.290 |
Why?
| | Thoracoscopy | 2 | 2019 | 60 | 0.280 |
Why?
| | Microbiota | 5 | 2023 | 782 | 0.280 |
Why?
| | Tympanic Membrane Perforation | 2 | 2020 | 17 | 0.260 |
Why?
| | Anesthesia | 2 | 2023 | 258 | 0.260 |
Why?
| | Delivery of Health Care | 1 | 2014 | 944 | 0.250 |
Why?
| | Treatment Outcome | 10 | 2023 | 11735 | 0.250 |
Why?
| | Mandibular Fractures | 1 | 2026 | 15 | 0.230 |
Why?
| | Nose Diseases | 1 | 2025 | 17 | 0.230 |
Why?
| | Hamartoma | 1 | 2025 | 29 | 0.230 |
Why?
| | Down Syndrome | 2 | 2023 | 522 | 0.230 |
Why?
| | Tracheobronchomalacia | 2 | 2022 | 15 | 0.220 |
Why?
| | Middle Ear Ventilation | 1 | 2024 | 18 | 0.220 |
Why?
| | Humans | 39 | 2026 | 144667 | 0.220 |
Why?
| | Cytokines | 1 | 2012 | 2045 | 0.220 |
Why?
| | Palatine Tonsil | 1 | 2024 | 55 | 0.210 |
Why?
| | Sutures | 2 | 2021 | 65 | 0.200 |
Why?
| | Constriction, Pathologic | 2 | 2023 | 249 | 0.200 |
Why?
| | Herpesvirus 4, Human | 1 | 2024 | 176 | 0.200 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2024 | 101 | 0.190 |
Why?
| | Croup | 1 | 2023 | 19 | 0.190 |
Why?
| | Cleft Palate | 1 | 2024 | 89 | 0.190 |
Why?
| | Laryngostenosis | 1 | 2023 | 54 | 0.190 |
Why?
| | Male | 23 | 2026 | 72431 | 0.190 |
Why?
| | Female | 23 | 2026 | 78304 | 0.180 |
Why?
| | Otolaryngology | 2 | 2020 | 108 | 0.170 |
Why?
| | Cadherin Related Proteins | 1 | 2021 | 12 | 0.170 |
Why?
| | Nasopharynx | 1 | 2022 | 73 | 0.170 |
Why?
| | Haemophilus Infections | 1 | 2022 | 45 | 0.170 |
Why?
| | Polytetrafluoroethylene | 1 | 2021 | 24 | 0.170 |
Why?
| | Down-Regulation | 2 | 2024 | 616 | 0.170 |
Why?
| | Ear, Middle | 4 | 2023 | 84 | 0.160 |
Why?
| | Job Satisfaction | 1 | 2023 | 235 | 0.160 |
Why?
| | Esophageal Atresia | 1 | 2020 | 32 | 0.160 |
Why?
| | Plasminogen | 1 | 2020 | 27 | 0.160 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2024 | 300 | 0.160 |
Why?
| | Respiratory Tract Fistula | 1 | 2019 | 7 | 0.150 |
Why?
| | Bronchiectasis | 1 | 2020 | 112 | 0.150 |
Why?
| | alpha-Macroglobulins | 1 | 2019 | 25 | 0.150 |
Why?
| | Otorhinolaryngologic Diseases | 1 | 2019 | 17 | 0.150 |
Why?
| | Digestive System Diseases | 1 | 2019 | 27 | 0.150 |
Why?
| | Laryngoscopy | 1 | 2020 | 119 | 0.140 |
Why?
| | Tracheotomy | 2 | 2019 | 23 | 0.140 |
Why?
| | Mutation, Missense | 1 | 2020 | 338 | 0.140 |
Why?
| | Airway Extubation | 1 | 2019 | 60 | 0.140 |
Why?
| | Symptom Assessment | 1 | 2019 | 136 | 0.140 |
Why?
| | Sleep Apnea Syndromes | 1 | 2019 | 96 | 0.140 |
Why?
| | Occipital Bone | 1 | 2018 | 18 | 0.140 |
Why?
| | Sphenoid Bone | 1 | 2018 | 15 | 0.140 |
Why?
| | Polysomnography | 1 | 2019 | 236 | 0.140 |
Why?
| | Skull Base | 1 | 2018 | 55 | 0.140 |
Why?
| | Respiration Disorders | 1 | 2018 | 78 | 0.130 |
Why?
| | Vascular Diseases | 1 | 2020 | 252 | 0.130 |
Why?
| | Respiratory Tract Diseases | 1 | 2019 | 175 | 0.130 |
Why?
| | Betacoronavirus | 1 | 2020 | 286 | 0.130 |
Why?
| | Bronchopulmonary Dysplasia | 1 | 2022 | 410 | 0.130 |
Why?
| | Gastrointestinal Diseases | 1 | 2018 | 217 | 0.120 |
Why?
| | Burnout, Professional | 1 | 2023 | 483 | 0.120 |
Why?
| | Osteomyelitis | 1 | 2018 | 141 | 0.120 |
Why?
| | Adolescent | 8 | 2026 | 22409 | 0.120 |
Why?
| | Sequence Analysis, DNA | 1 | 2019 | 828 | 0.120 |
Why?
| | Postoperative Complications | 2 | 2019 | 2950 | 0.120 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2019 | 299 | 0.110 |
Why?
| | RNA, Ribosomal, 16S | 3 | 2023 | 564 | 0.110 |
Why?
| | Pandemics | 2 | 2024 | 1700 | 0.110 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 387 | 0.110 |
Why?
| | Coronavirus Infections | 1 | 2020 | 381 | 0.110 |
Why?
| | Membrane Proteins | 1 | 2021 | 1159 | 0.110 |
Why?
| | Pitch Perception | 1 | 2014 | 14 | 0.100 |
Why?
| | Pedigree | 3 | 2020 | 515 | 0.100 |
Why?
| | Severity of Illness Index | 2 | 2019 | 2922 | 0.100 |
Why?
| | Tympanoplasty | 1 | 2014 | 9 | 0.100 |
Why?
| | Auditory Threshold | 1 | 2014 | 51 | 0.100 |
Why?
| | Carcinoma, Squamous Cell | 2 | 2011 | 643 | 0.100 |
Why?
| | Follow-Up Studies | 4 | 2019 | 5414 | 0.100 |
Why?
| | Fistula | 1 | 2014 | 49 | 0.100 |
Why?
| | Genetic Variation | 1 | 2018 | 985 | 0.100 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2014 | 73 | 0.100 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2014 | 106 | 0.100 |
Why?
| | Ion Transport | 1 | 2012 | 62 | 0.090 |
Why?
| | Respiratory Syncytial Viruses | 1 | 2012 | 58 | 0.090 |
Why?
| | Rhinovirus | 1 | 2012 | 60 | 0.090 |
Why?
| | Ear, Inner | 1 | 2012 | 51 | 0.090 |
Why?
| | Gene Expression Profiling | 1 | 2019 | 1766 | 0.090 |
Why?
| | Coronavirus | 1 | 2012 | 47 | 0.090 |
Why?
| | Suture Techniques | 1 | 2013 | 137 | 0.090 |
Why?
| | Bronchiolitis | 1 | 2012 | 87 | 0.090 |
Why?
| | Mutation | 2 | 2021 | 4081 | 0.090 |
Why?
| | Infant, Newborn | 3 | 2023 | 6399 | 0.090 |
Why?
| | Asthma | 1 | 2023 | 1774 | 0.080 |
Why?
| | Papillomaviridae | 1 | 2011 | 114 | 0.080 |
Why?
| | Gastroesophageal Reflux | 1 | 2012 | 236 | 0.080 |
Why?
| | Combined Modality Therapy | 1 | 2013 | 1268 | 0.080 |
Why?
| | Polymorphism, Genetic | 1 | 2012 | 613 | 0.080 |
Why?
| | Hospitals, Pediatric | 3 | 2019 | 557 | 0.080 |
Why?
| | Stress, Physiological | 1 | 2012 | 451 | 0.070 |
Why?
| | Respiratory Tract Infections | 1 | 2012 | 395 | 0.070 |
Why?
| | Length of Stay | 1 | 2014 | 1339 | 0.070 |
Why?
| | Bacteria | 1 | 2012 | 894 | 0.060 |
Why?
| | Ribonuclease III | 1 | 2025 | 44 | 0.060 |
Why?
| | Age Factors | 1 | 2013 | 3329 | 0.060 |
Why?
| | DEAD-box RNA Helicases | 1 | 2025 | 89 | 0.050 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2011 | 1145 | 0.050 |
Why?
| | Multiple Trauma | 1 | 2026 | 121 | 0.050 |
Why?
| | Surgical Flaps | 1 | 2005 | 142 | 0.050 |
Why?
| | Continuous Positive Airway Pressure | 1 | 2024 | 89 | 0.050 |
Why?
| | Adult | 5 | 2024 | 40489 | 0.050 |
Why?
| | Young Adult | 4 | 2023 | 14122 | 0.050 |
Why?
| | Mice | 4 | 2022 | 18261 | 0.050 |
Why?
| | Accidental Falls | 1 | 2026 | 221 | 0.050 |
Why?
| | Genetic Testing | 1 | 2025 | 480 | 0.050 |
Why?
| | Cough | 1 | 2023 | 123 | 0.040 |
Why?
| | Genetic Predisposition to Disease | 2 | 2021 | 2350 | 0.040 |
Why?
| | Haemophilus influenzae | 1 | 2022 | 67 | 0.040 |
Why?
| | Perioperative Period | 1 | 2020 | 70 | 0.040 |
Why?
| | Adrenal Cortex Hormones | 1 | 2023 | 480 | 0.040 |
Why?
| | Philippines | 1 | 2019 | 51 | 0.040 |
Why?
| | Pakistan | 1 | 2019 | 79 | 0.040 |
Why?
| | Finland | 1 | 2019 | 78 | 0.040 |
Why?
| | Speech-Language Pathology | 1 | 2019 | 23 | 0.040 |
Why?
| | Mice, Inbred C57BL | 2 | 2021 | 5967 | 0.040 |
Why?
| | Colorado | 2 | 2019 | 4558 | 0.040 |
Why?
| | Athletic Injuries | 1 | 2026 | 571 | 0.040 |
Why?
| | Statistics, Nonparametric | 1 | 2019 | 427 | 0.040 |
Why?
| | Esophageal pH Monitoring | 1 | 2018 | 22 | 0.040 |
Why?
| | Saliva | 1 | 2020 | 247 | 0.040 |
Why?
| | Social Support | 1 | 2023 | 650 | 0.040 |
Why?
| | Clinical Protocols | 1 | 2020 | 282 | 0.030 |
Why?
| | COS Cells | 1 | 2018 | 177 | 0.030 |
Why?
| | Consensus | 1 | 2020 | 475 | 0.030 |
Why?
| | Pulmonary Medicine | 1 | 2019 | 78 | 0.030 |
Why?
| | Skin Neoplasms | 1 | 2005 | 850 | 0.030 |
Why?
| | Electric Impedance | 1 | 2018 | 110 | 0.030 |
Why?
| | Animals | 4 | 2022 | 37948 | 0.030 |
Why?
| | Device Removal | 1 | 2019 | 142 | 0.030 |
Why?
| | Efficiency, Organizational | 1 | 2019 | 140 | 0.030 |
Why?
| | Emotions | 1 | 2023 | 578 | 0.030 |
Why?
| | ROC Curve | 1 | 2019 | 618 | 0.030 |
Why?
| | Infant, Premature | 1 | 2022 | 614 | 0.030 |
Why?
| | Exome | 1 | 2018 | 227 | 0.030 |
Why?
| | Risk Factors | 2 | 2024 | 10796 | 0.030 |
Why?
| | Anesthetics | 1 | 2018 | 99 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2019 | 442 | 0.030 |
Why?
| | Gastroenterology | 1 | 2019 | 190 | 0.030 |
Why?
| | Ambulatory Care Facilities | 1 | 2018 | 267 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2018 | 743 | 0.030 |
Why?
| | Recurrence | 1 | 2019 | 1136 | 0.030 |
Why?
| | Perioperative Care | 1 | 2018 | 231 | 0.030 |
Why?
| | Comorbidity | 1 | 2020 | 1652 | 0.030 |
Why?
| | Hospitalization | 1 | 2026 | 2446 | 0.030 |
Why?
| | Genomics | 1 | 2020 | 831 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2019 | 1995 | 0.030 |
Why?
| | Transcriptome | 1 | 2021 | 1036 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2019 | 1103 | 0.030 |
Why?
| | Program Evaluation | 1 | 2019 | 941 | 0.030 |
Why?
| | Patient Satisfaction | 1 | 2019 | 707 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2019 | 2117 | 0.030 |
Why?
| | Audiometry, Pure-Tone | 1 | 2014 | 33 | 0.030 |
Why?
| | Quality of Health Care | 1 | 2019 | 692 | 0.030 |
Why?
| | Bone Conduction | 1 | 2014 | 27 | 0.030 |
Why?
| | Biomarkers | 1 | 2024 | 4261 | 0.020 |
Why?
| | Cell Line | 1 | 2018 | 2821 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2020 | 2137 | 0.020 |
Why?
| | Reoperation | 1 | 2016 | 624 | 0.020 |
Why?
| | Tertiary Care Centers | 1 | 2014 | 194 | 0.020 |
Why?
| | Graft Rejection | 1 | 2016 | 512 | 0.020 |
Why?
| | Speech Perception | 1 | 2014 | 92 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2019 | 3414 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2020 | 2754 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2023 | 6041 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2019 | 2591 | 0.020 |
Why?
| | Inflammation | 1 | 2021 | 2870 | 0.020 |
Why?
| | Time Factors | 1 | 2019 | 7140 | 0.020 |
Why?
| | Lung | 1 | 2020 | 4089 | 0.020 |
Why?
| | Prospective Studies | 1 | 2018 | 7994 | 0.010 |
Why?
| | Signal Transduction | 1 | 2019 | 5185 | 0.010 |
Why?
| | Lymphatic Metastasis | 1 | 2005 | 334 | 0.010 |
Why?
| | Cohort Studies | 1 | 2014 | 5957 | 0.010 |
Why?
| | Middle Aged | 2 | 2019 | 35971 | 0.010 |
Why?
| | United States | 1 | 2019 | 16018 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2005 | 8284 | 0.010 |
Why?
| | Aged | 1 | 2005 | 25955 | 0.000 |
Why?
|
|
Wine's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|